You are here: Industry Insights > opioid

News List

Rising levels of opioid prescriptions puts NHS under pressure pharmafile
March 19, 2018
It has been found that the number of prescriptions being written for opioid painkillers has risen from 10 million to 23.8 million, from 2007 to 2017.
Q Biomed Inc. Announces FDA Filing for Approval of a New Manufacturing Facility for Non-Opioid Stron biospace
March 19, 2018
Bio-Nucleonics, licensor of Strontium 89 Chloride, announce submission of a regulatory filing to the FDA for the approval of a new manufacturing facility.
FDB Releases Opioid Risk Management Drug Knowledge to Reduce the Risk of Opioid-Related Overdose and biospace
March 16, 2018
FDB announced the release of the FDB Opioid Risk Management Module™ that helps reduce the risk of opioid-related overdose and addiction potential.
CDC Report Indicates Opioid Crisis in America is Worsening biospace
March 08, 2018
America’s opioid epidemic is getting worse.
Fifty-Two Week Safety Study on Symproic® (naldemedine) for Opioid-induced Constipation (OIC) in Adul biospace
March 07, 2018
Shionogi, Inc and Purdue Pharma, L.P. today announced the publication of a study known as COMPOSE-3.
Mallinckrodt subpoenaed, again, over sales of oxymorphone in growing opioid crisis fiercepharma
March 01, 2018
Mallinckrodt has received another subpoena seeking information about its sales of the powerful painkillers.
FDA, FTC Warn Companies for Selling Illegal, Unapproved Opioid Cessation Products Using Deceptive Cl americanpharmaceuticalreview
January 25, 2018
The United States Food and Drug Administration (FDA) and the Federal Trade Commission (FTC) sent a joint warning letter to vendors and distributors of 12 opiate smoking cessation products
Heroin vaccine could be a treatment for opioid addiction europeanpharmaceuticalreview
December 19, 2017
New research shows that experimental vaccine produces antibodies against commonly misused opioids, including heroin, hydrocodone, oxycodone, hydromorphone, oxymorphone and codeine.
US ASTHO seeks $1bn funding for opioid epidemic pharmaceutical-technology
December 06, 2017
The Association of State and Territorial Health Officials (ASTHO), a US non-profit organisation, has requested the Administration and Congress to provide $1bn emergency supplemental funding to address opioid epidemic in the country.
First and only medicine of its kind for opioid use disorder approved by FDA pharmafile
December 04, 2017
FDA has announced the approvement of the first and only monthly buprenorphine injections which can now be used to treat moderate to severe opioid abuse

Previous page 1 2 3 4 5 6 7 8 9 10 ... 21 22 Next page